We are making no changes to our fair value estimate for the wide-moat firm despite outflows and market losses from the first quarter.
We continue to view this wide-moat stock as undervalued and maintain our fair value estimate.
The wide-moat firm faces market headwinds, but we anticipate its outlook will reverse in 2021.
We are not changing our fair value estimate for this wide-moat firm after its first-quarter showed resilience and sustainable performance.
Results from this wide-moat rated company are firmly in line with our expectations.
Overall, while we agree that near-term headwinds are fierce, we continue think that there are long-term tailwinds for the firm.
The move to us is about debt extension, and we believe it does not create new funding for the automaker.
We are maintaining our fair value estimate for the narrow-moat firm.
The commercial aerospace environment faces rapid degradation relative to prior expectations.
We are maintaining our $70 fair value estimate for wide-moat Intel. Shares look attractive at current levels.
We don’t anticipate making a material change to our fair value estimate for the narrow-moat firm and assess shares as moderately undervalued.
We are not making a large change to our fair value estimate and expect the firm to recover in the long term.
We don’t plan a material change to our fair value estimate.
We don't anticipate making a material change to our fair value estimate and assess the shares as modestly undervalued.
It's difficult to say with any certainty when air traffic will return, but we are confident that demand will eventually bounce back.
We see shares as attractive for the narrow-moat firm and don't plan to change our fair value estimate.
We decrease our fair value estimate for the no-moat firm after the airline industry has been grounded due to the COVID-19 pandemic.
Sycamore is attempting unwind the deal for the narrow-moat firm.
We are maintaining our fair value estimate after first-quarter results show resilience.
We plan to raise our fair value estimate to reflect future market share gains, but shares are still overvalued.
Despite subscriber additions ahead of our estimate, revenue for the narrow-moat company was only 1% ahead of our projections for the first quarter.
The no-moat firm posted strong first-quarter results.
Shares of the wide-moat firm offer compelling value at current prices.
Our fair value estimate remains intact, and we see shares as significantly undervalued.
We could lower our fair value estimate modestly but still see value in shares at current levels.
Widespread social distancing due to the coronavirus has dragged down gasoline consumption and storage utilization is rapidly climbing.
We don't expect to alter our fair value estimate or long-term outlook for the wide-moat firm, but we think investors should await a more attractive risk/return opportunity.
We're maintaining our $82 fair value estimate for the wide-moat firm while we await more data from the testing.
The wide-moat firm's organic growth, market losses, and adverse currency exchange all were slightly worse than our own projections.
We have incorporated the latest rate cuts and expectations for lower fee income, leading us to a new fair value estimate for Citigroup of $72, down from our previous estimate of $79.
For this wide-moat firm, we don't anticipate making a material change to our fair value estimate and currently assess shares as modestly undervalued.
We slightly lowered our fair value estimate for this wide-moat firm after it reported weaker first-quarter earnings.
Results and outlook for the wide-moat firm bode well for the discounted managed-care industry, and shares appear moderately undervalued.
We have also incorporated the latest rate cuts and expectations for lower fee income, leading to a new fair value estimate for JPMorgan of $113, down from $117.
We're lowering our fair-value estimate for the wide-moat firm.
We expect J&J to lead the charge in developing a coronavirus vaccine and view the stock as slightly overvalued.
The wide-moat firm is preparing for loan losses after weak results.
We expect the no-moat firm to survive the damage without going bankrupt.
We believe specialty coffee will be one of the restaurant categories hardest hit by coronavirus disruptions, but we're not planning to change our fair value estimate on this wide-moat firm.
Based on our sales forecast, we think this wide-moat firm can maintain its dividend.
This no-moat firm is winning with consumers amid COVID-19, but we don’t think this growth will prove sustainable.
We're reducing our fair value estimate on the wide-moat firm.
We expect to reduce our fair value estimate on the wide-moat brand because of COVID-19, but we believe it will come through the crisis better than most peers.
We have reduced our near-term outlook for lithium demand and maintain our current forecasts for three narrow-moat companies.
We are not changing our fair value estimate for the no-moat firm.
We have reduced our fair value estimate and we view shares as undervalued.
Our base case calls for a strong economic rebound in 2021 following a recession in 2020.
Investors should watch for names with value, technology, healthy balance sheets.
With rates cut to zero, investors should be seriously watching and considering bank stocks as this plays out.